← Open Payments lookup

MARK MCGRATH: Open Payments

NPI 1659870178 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$207 in 11 payments from 7 companies in 2025. Trend: 2023 $264 · 2024 $183 · 2025 $207

Food & beverage: $207
CompanyPaymentsAmount
ABBVIE INC.3$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$35
Neurocrine BioSciences, Inc.2$34
Vanda Pharmaceuticals Inc.1$32
Axsome Therapeutics, Inc.1$28
Indivior Inc.1$17
Teva Pharmaceuticals USA, Inc.1$16

Products named: VRAYLAR, CAPLYTA, INGREZZA, FANAPT, Auvelity, SUBLOCADE, AUSTEDO XR.

Industry payments across MT — which companies pay providers there.